UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000020137 |
|---|---|
| Receipt number | R000023260 |
| Scientific Title | Improvement of joint pain and safety by ingestion of supplement containing glucosamine: a randomized, double blind, placebo-controlled study |
| Date of disclosure of the study information | 2015/12/09 |
| Last modified on | 2016/09/01 15:19:38 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Improvement of joint pain and safety by ingestion of supplement containing glucosamine: a randomized, double blind, placebo-controlled study
Acronym
Improvement of joint pain and safety by ingestion of supplement containing glucosamine
Scientific Title
Improvement of joint pain and safety by ingestion of supplement containing glucosamine: a randomized, double blind, placebo-controlled study
Scientific Title:Acronym
Improvement of joint pain and safety by ingestion of supplement containing glucosamine
Region
| Japan |
Condition
Condition
Healthy adult
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
This study aims to evaluate improvement of joint pain (in knee, elbow, and back), and safety by ingestion of supplement containing glucosamine consecutively on healthy adult.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
2-step test (locomotion test), subjective evaluation (J-KOOS, JKOM, HAQ, ODI) <before and after ingestion of supplement for 16 weeks>
Key secondary outcomes
safety <before and after ingestion of supplement for 16 weeks>
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Intake test sample for 16 weeks
Interventions/Control_2
Intake placebo for 16 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 30 | years-old | <= |
Age-upper limit
| 69 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Male and female between 30 and 69 years of age
Key exclusion criteria
1. Subjects with joint pain caused by gout or rheumatism
2. Subjects with surgical experience for knee or elbow
3. Subjects with a history of fracture or sprain within the past 3 months
4. Subject with a past history of diseases in heart, kidney, liver, digestive organ, blood vessels or metabolism
5. Subjects who consume food or medicinal product containing glucosamine, chondroitin or hyaluronan
6. Subjects with food allergies
7. Subjects who are pregnant or lactating
8. Subjects who are judged as unsuitable for the study by the investigator for other reasons
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Masatomo Najima |
Organization
Japan clinical trial association
Division name
N.A.
Zip code
Address
8F, 5-27-3 sendagaya, shibuyaku, Tokyo
TEL
03-6457-4666
info@yakujihou.org
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Hirohisa Kojima |
Organization
Japan clinical trial association
Division name
N.A.
Zip code
Address
8F, 5-27-3 sendagaya, shibuyaku, Tokyo
TEL
03-6457-4666
Homepage URL
info@yakujihou.org
Sponsor or person
Institute
Japan clinical trial association
Institute
Department
Personal name
Funding Source
Organization
Yawata Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 12 | Month | 09 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2015 | Year | 10 | Month | 29 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 12 | Month | 09 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2015 | Year | 12 | Month | 09 | Day |
Last modified on
| 2016 | Year | 09 | Month | 01 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023260
